1. Home
  2. YHGJ vs MBAI Comparison

YHGJ vs MBAI Comparison

Compare YHGJ & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yunhong Green CTI Ltd.

YHGJ

Yunhong Green CTI Ltd.

N/A

Current Price

$3.54

Market Cap

11.2M

Sector

Industrials

ML Signal

N/A

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$2.13

Market Cap

10.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
YHGJ
MBAI
Founded
1975
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Specialty Chemicals
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.2M
10.6M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
YHGJ
MBAI
Price
$3.54
$2.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
18.1K
6.9M
Earning Date
11-13-2025
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,377,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.41
N/A
52 Week Low
$3.37
$0.59
52 Week High
$12.70
$3.92

Technical Indicators

Market Signals
Indicator
YHGJ
MBAI
Relative Strength Index (RSI) 42.83 54.90
Support Level $3.43 $1.63
Resistance Level $3.92 $3.92
Average True Range (ATR) 0.34 0.33
MACD -0.01 0.07
Stochastic Oscillator 11.89 26.32

Price Performance

Historical Comparison
YHGJ
MBAI

About YHGJ Yunhong Green CTI Ltd.

Yunhong Green CTI Ltd manufactures and marketers of foil balloons and produces laminated and printed films for commercial uses. The company also distributes balloon-inspired and other gift items, and continues development of compostable material solutions, and markets its products throughout the United States and in several other countries.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: